The Internal Revenue Service alleged that Bristol Myers Squibb used an “abusive” tax shelter to avoid $1.4 billion in federal taxes. The agency said BMS dodged its tax bill by moving profits through an offshore subsidiary created in Ireland nine years ago. (The New York Times)

Three members of the advisory committee that reviewed Biogen’s Alzheimer’s therapy aducanumab last fall urged the Food and Drug Administration to reject the drug. “There is no persuasive evidence to support approval of aducanumab at this time,” they wrote in an op-ed in The Journal of the American Medical Association. (Endpoints News)

The Biden administration has begun airing the first TV ads in its campaign to increase vaccine confidence. The campaign includes targeted advertising spots across Black and Spanish-language platforms. (The Washington Post)

The White House was aware of production problems at a contractor for the Johnson & Johnson vaccine weeks before contamination. The contractor, Emergent BioSolutions, contaminated 15 million doses by accidentally mixing it with ingredients from another COVID-19 vaccine. (Politico)

Seema Verma, the Centers for Medicare and Medicaid administrator during the Trump administration, is joining the Lumeris board of directors. The company focuses on value-based reimbursement requirements, though Verma has previously some criticized value-based care models. (STAT)